Your browser doesn't support javascript.
loading
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.
Williams, Bryan; MacDonald, Thomas M; Morant, Steve V; Webb, David J; Sever, Peter; McInnes, Gordon T; Ford, Ian; Cruickshank, J Kennedy; Caulfield, Mark J; Padmanabhan, Sandosh; Mackenzie, Isla S; Salsbury, Jackie; Brown, Morris J.
Afiliação
  • Williams B; UCL Institute of Cardiovascular Sciences, University College London, London, UK; National Institute for Health Research, UCL Hospitals Biomedical Research Centre, London, UK.
  • MacDonald TM; Medicines Monitoring Unit, Molecular and Clinical Medicine, University of Dundee, Dundee, UK.
  • Morant SV; Medicines Monitoring Unit, Molecular and Clinical Medicine, University of Dundee, Dundee, UK.
  • Webb DJ; Clinical Pharmacology Unit, Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
  • Sever P; Centre of Circulatory Health, Imperial College London, London, UK.
  • McInnes GT; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Ford I; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
  • Cruickshank JK; Department of Nutritional Sciences, King's College London, London, UK.
  • Caulfield MJ; William Harvey Research Institute, Queen Mary University of London, London, UK; NIHR Barts Hospital Biomedical Research Centre, London, UK.
  • Padmanabhan S; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Mackenzie IS; Medicines Monitoring Unit, Molecular and Clinical Medicine, University of Dundee, Dundee, UK.
  • Salsbury J; William Harvey Research Institute, Queen Mary University of London, London, UK; NIHR Barts Hospital Biomedical Research Centre, London, UK.
  • Brown MJ; William Harvey Research Institute, Queen Mary University of London, London, UK; NIHR Barts Hospital Biomedical Research Centre, London, UK. Electronic address: morris.brown@qmul.ac.uk.
Lancet Diabetes Endocrinol ; 6(6): 464-475, 2018 06.
Article em En | MEDLINE | ID: mdl-29655877
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espironolactona / Pressão Sanguínea / Doxazossina / Bisoprolol / Hipertensão / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espironolactona / Pressão Sanguínea / Doxazossina / Bisoprolol / Hipertensão / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article